Lyme disease: diagnostics and treatment in therapeutical practice
- Авторлар: Fomin VV1, Lebedeva MV1, Fomin V1, Lebedeva M1
-
Мекемелер:
- Шығарылым: № 4 (2010)
- Беттер: 32-36
- Бөлім: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/278291
- ID: 278291
Дәйексөз келтіру
Толық мәтін
Аннотация
The features of the epidemiology and clinical performance of Lyme disease (LD), described by the Swiss microbiologist Willi Burgdorfer, are considered. We discuss the current principles of diagnosis of LD. Drugs of choice in the treatment of LB are cephalosporins III generation, penicillin G, doxycycline, and macrolides, primarily azithromycin, which have demonstrated superiority over a number of other antibacterial agents in clinical trials. With early start, the effectiveness of antibacterial therapy of LB is maximum, determining the validity of the formation of an appropriate diagnosis of this disease by clinicians.
Негізгі сөздер
Әдебиет тізімі
- Steere AC, Malawista SE, Snydman DR, et al. Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three Connecticut communities. Arthritis Rheum 1977;20(1):7-17.
- Bratton RL, Whiteside JW, Hovan MJ, et al. Diagnosis and treatment of Lyme disease. Mayo Clin Proc 2008;83(5):566-71.
- Stanek G, Strle F. Lyme borreliosis. Lancet 2003;362:1639-47.
- Marques A. Chronic Lyme disease: an appraisal. Infect Dis Clin North Am 2008;22(2):341-60.
- Pinto DS. Cardiac manifestations of Lyme disease. Med Clin North Am 2002;86(2):285-96.
- Steere AC, Dwyer E, Winchester R. Association of chronic Lyme arthritis with HLA-DR4 and HLA-DR2 alleles. N Engl J Med 1990;323(6):219-23.
- Steere AC, Klitz W, Drouin EE, et al. Antibiotic-refractory Lyme arthritis is associated with HLA-DR molecules that bind a Borrelia burgdorferi peptide. J Exp Med 2006;203(4):961-71.
- Nowakowski J, Nadelman RD, Sell R, et al. Long-term follow-up of patients with culture-confirmed Lyme disease. Am J Med 2003;115(2):91-96.
- Picha D, Moravcova L, Lasikova S, et al. Symptoms of post-Lyme syndrome in long-term outcome of patients with neuroborreliosis. Sacnd J Infect Dis 2006;38(8):747-48.
- Strle F, Ruzic E, Cimperman J. Erythema migrans: comparison of treatment with azithromycin, doxycycline and phenoxymethylpenicillin. J Antimicrob Chemother 1992;30(4):543-50.
- Strle F, Preac-Mursic V, Cimperman J, et al. Azithromycin versus doxycycline for treatment of erythema migrans: clinical and microbiological findings. Infection 1993;21(2):83-88.
- Preac-Mursic V, Wilske B, Schierz G, et al. Comparative antimicrobial activity of the new macrolides against Borrelia burgdorferi. Eur J Clin Microbiol Infect Dis 1989;8(7):651-53.
- Johnson RC, Kodner C, Russell M, et al. In-vitro and in-vivo susceptibility of Borrelia burgdorferi to azithromycin. J Antimicrob Chemother 1990;(25 Suppl. A):33-38.
- Weber K, Wilske B, Preac-Mursic V, et al. Azithromycin versus penicillin V for the treatment of early Lyme borreliosis. Infection 1993;21(6):367-72.
- Strle F, Maraspin V, Lotric-Furlan S, et al. Azithromycin and doxycycline for treatment of Borrelia culture-positive erythema migrans. Infection 1996;24(1):64-68.
- Barsic B, Maretic T, Majerus L, et al. Comparison of azithromycin and doxycycline in the treatment of erythema migrans. Infection. 2000;28(3):153-56.
- Arnez M, Pleterski-Rigler D, Luznik-Bufon T, et al. Solitary erythema migrans in children: comparison of treatment with azithromycin andphenoxymethylpenicillin. Wien Klin. Wochenschr 2002;114(13-14):498-504.
- Cordonnier P, Iltis C, Martinez C, et al. Neuroborreliosis after an early Lyme disease treated by azithromycin. Med Mal Infect 2009 Nov 27. [Epub ahead of print]
Қосымша файлдар
